Studies show improved outcomes in models of osteoarthritis and joint damage, likely mediated through growth factor upregulation and anti-inflammatory pathways
Another common preclinical model involves using chemically induced damage, such as oxidative stress or inflammation, to test the peptides potential in mitigating cellular damage
Semaglutide reduces blood glucose through a mechanism where it stimulates insulin secretion and lowers Glc secretion, both in a glucose-dependent manner
[ref] As wounds and damaged tissue heal, they rely on the formation of new blood vessels, which is another way that BPC-157 promotes healing.[ref] BPC-157 increases the formation of blood vessels by increasing the expression of vascular endothelial growth factor receptor 2 (VEGFR2)
Unfortunately, if you have a deficiency, its likely you also do not produce enough intrinsic factor, or your body has difficulty absorbing it